Haig Keledjian - Vg Life Chairman
| VGLS Stock | USD 0.0001 0.00 0.00% |
Chairman
Mr. Haig Keledjian is Founder, Chairman of the Board, Chief Executive Officer, Chief Financial Officer, Vice President Research Development, Secretary of the Company. He was appointed to the position of Chief Executive Officer, Chief Financial Officer of the Company., effective 1 April 2016 since 2016.
| Age | 61 |
| Tenure | 8 years |
| Phone | 805 879 9000 |
| Web | https://www.vglifesciences.com |
Vg Life Management Efficiency
The company has return on total asset (ROA) of (1.5118) % which means that it has lost $1.5118 on every $100 spent on assets. This is way below average. Vg Life's management efficiency ratios could be used to measure how well Vg Life manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 5 records | CHAIRMAN Age | ||
| Wun Tse | Sino Biopharmaceutical Limited | 56 | |
| Y Tse | Sino Biopharmaceutical Limited | 31 | |
| Fai Chia | Sino Biopharmaceutical Limited | 65 | |
| Anthony Esq | Dominari Holdings | 56 | |
| Eric Weisblum | Silo Pharma | 54 | |
Management Performance
| Return On Asset | -1.51 |
Vg Life Sciences Leadership Team
Elected by the shareholders, the Vg Life's board of directors comprises two types of representatives: Vg Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of VGLS. The board's role is to monitor Vg Life's management team and ensure that shareholders' interests are well served. Vg Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vg Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Forrester, Co Counsel | ||
| Haig Keledjian, Chairman of the Board, Vice President - Intellectual Property and Product Development | ||
| Robert Berliner, Consultant Member | ||
| Karen NewellRogers, Chief Scientist |
VGLS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Vg Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -1.51 | |||
| Current Valuation | 4.44 M | |||
| Shares Outstanding | 107.88 M | |||
| Price To Earning | (0.14) X | |||
| Price To Book | 32.38 X | |||
| EBITDA | (3.43 M) | |||
| Net Income | (6.19 M) | |||
| Cash And Equivalents | 22.92 K | |||
| Total Debt | 3.38 M | |||
| Current Ratio | 0.01 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VGLS Pink Sheet Analysis
When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.